Hepatitis C Pipeline Comparative Analysis at Various Stages 2015

RnRMarketResearch.com Directs “Hepatitis C Pipeline Review, H1 2015′ to its Store. This report provides comprehensive information on the therapeutic development for Hepatitis C, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatitis C and special features on late-stage and discontinued projects.

 Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Scope

·         The report provides a snapshot of the global therapeutic landscape of Hepatitis C

·         The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

·         The report reviews key players involved in the therapeutics development for Hepatitis C and enlists all their major and minor projects

·         The report summarizes all the dormant and discontinued pipeline projects

·         A review of the Hepatitis C products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

·         Pipeline products coverage based on various stages of development ranging from per-registration till discovery and undisclosed stages

·         A detailed assessment of mono therapy and combination therapy pipeline projects

Complete report on H1, 2015 Pipeline Review of “Hepatitis C” addiction with 171 market data tables and 17 figures, spread across 639 pages is http://www.rnrmarketresearch.com/hepatitis-c-pipeline-review-h1-2015-market-report.html . (This is a premium report price at US$2000 for a single user PDF license)

Reasons to Buy:

• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Develop strategic initiatives by understanding the focus areas of leading companies
• Identify and understand important and diverse types of therapeutics under development for Hepatitis C
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
• Devise corrective measures for pipeline projects by understanding Hepatitis C pipeline depth and focus of Indication therapeutics
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Inquire for discount on this report at http://www.rnrmarketresearch.com/contacts/discount?rname=310120 .

More reports on Hepatitis Drugs :

Boceprevir – Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

This report covers:
International Nonproprietary Name: Boceprevir
Indications: Treatment of chronic hepatitis C genotype 1 infection in combination with Peginterferon alfa and Ribavirin
Innovator:Merck (Victrelis)
Country Coverage:
# Albania
# Australia
# Austria
# Belgium
# Bosnia & Herzegovina
# Brazil
# Bulgaria
# Canada and Many More
Complete report is available at http://www.rnrmarketresearch.com/boceprevir-patent-extension-and-data-exclusivity-expiry-snapshot-50-countries-market-report.html .

Global HIX IT Industry Trends & Forecasts to 2018

The report “Health Insurance Exchange (HIX) IT Market by Type (Public, & Private Exchanges), Phase (Implementation, QA, Operations), Component (Services, Software, Hardware), End User (Government Agencies, TPAs, Health Plans) – Trends & Global Forecasts to 2018″ by MarketsandMarkets is now available at RnRMarketResearch.com. Contact sales@rnrmarketresearch.com with Health Insurance Exchange (HIX) IT Market by Type (Public, & Private Exchanges), Phase (Implementation, QA, Operations), Component (Services, Software, Hardware), End User (Government Agencies, TPAs, Health Plans) – Trends & Global Forecasts to 2018 in subject line and your contact details to purchase this report or get your questions answered.

The global HIX ITmarket is valued at an estimated $1,609 million in 2013 and is expected to grow at a CAGR of 10.5% in the next five years.

The global HIX IT market is mainly categorized by exchange type, phase, component, and end user. Private exchanges are expected to register the fastest growth rate among the HIX market by exchange type during the forecast period.Their favorable growth is attributed to the increasing shift of big employers such as Walgreen and Time Warner towards private exchanges to reduce health benefits administration costs and provide their employees with multiple plan options as per their requirements. Within private exchanges, multi-carrier exchanges primarily sponsored by third-party administrators such as brokers or benefits consultantsare expected to grow at the highest CAGR during the forecast period.

Request a sample @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=159216 .

The other high-growth market segments in the HIX IT market include the operations and maintenance segment which is expected to grow at a highest CAGR during the forecast period. The factors contributing to its growth include ongoing operation cost for public as well as private exchanges post its implementation. The HIX servicesmarket is also projected to register a double-digit growth in the next five years, driven by the shift toward cloud-based services.

The U.S. shows the greatest market potential in the near future. However, countries such as Japan, China, India, and Philippines are expected to offer potential growth opportunities to HIX stakeholders. In Japan, various favorable government initiatives are focusing on strengthening healthcare services such as the e-Japan policy, new IT reform strategy, and iJApan Strategy 2015. The healthcare IT expenditure in China grew from $135 billion in 2006 to $250 billion in 2010. In addition, the Indian government annually spends approximately 5% of its GDP on the healthcare sector and has approved 100% foreign direct investment (FDI) for setting up hospitals in India since 2000. Also, it is among the leading IT outsourcing destinations. All the above mentioned factors contribute to the potential growth opportunity of the HIX market.

The competitive landscape covers the growth strategies adopted by industry players in the last three years. The company profiles comprise the basic views on the key players in the HIXmarket and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help the key players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Complete report (174 Pages) available @ http://www.rnrmarketresearch.com/health-insurance-exchange-hix-it-market-by-type-public-private-exchanges-phase-implementation-qa-operations-component-services-software-hardware-end-user-government-agencies-tpas-market-report.html .

Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)*

10.1 Accenture PLC
10.2 CGI Group, Inc.
10.3 Connecture Inc.
10.4 Cognosante, LLC
10.5 Deloitte
10.6 Hcentive, Inc.
10.7 Infosys
10.8 Maximus
10.9 Oracle Corporation
10.10 Xerox Corporation

Buy a copy of report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=159216 .

For further information on “Health Insurance Exchange (HIX) IT Market by Type (Public, & Private Exchanges), Phase (Implementation, QA, Operations), Component (Services, Software, Hardware), End User (Government Agencies, TPAs, Health Plans) – Trends & Global Forecasts to 2018” report OR for any other business research / market intelligence need on the ‘Insurance & Managed Care Company’ market (http://www.rnrmarketresearch.com/reports/life-sciences/healthcare/insurance-managed-care/insurance-managed-care-company .) contact sales@rnrmarketresearch.com / Call +1 888 391 5441.

Global Healthcare Information Exchange Industry (HIE) - Trends & Forecast to 2018

The report “Healthcare Information Exchange (HIE) Market by Setup Types (Public & Private), Vendors (Web Portal & Platform), Implementation Models (Centralized, Federated, & Hybrid), Application (Interfacing, Secure Messaging) – Global Trends & Forecast to 2018″ by MarketsandMarkets is now available at RnRMarketResearch.com. Contact sales@rnrmarketresearch.com with Healthcare Information Exchange (HIE) Market by Setup Types (Public & Private), Vendors (Web Portal & Platform), Implementation Models (Centralized, Federated, & Hybrid), Application (Interfacing, Secure Messaging) – Global Trends & Forecast to 2018 in subject line and your contact details to purchase this report or get your questions answered.

The platform centric segment and hybrid models pose significant growth opportunities for the HIE market
The global HIEmarket is valued at an estimated $558million in 2013 and is expected to grow at a CAGR of 9.5% in the next five years.
The global HIE systems market is mainly categorized by set-up type, vendor, implementation model, and by application.
The incentives by the U.S. federal government, improvements in patient care and safety, and reduction in healthcare costswill be the major drivers for this market.However, factors such as high implementation costs, slow returns on investment, and interoperability issues are hampering the market growth. The increasing demand for cloud-based services and mobile health applications in the emerging markets are encouraging the growth of the HIEmarket. The federated or decentralized modelsmarket commands the largest share of the HIE implementation models market in 2013. However, the hybrid models market is estimated to grow at the highestCAGR of 14.4% during the study period.

Inquire a Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=155326 .

The hybrid models segment is projected to witness a robust growth during the forecast period driven by the factors such as enhanced control of patient data and compatibility with several interfaces among communities.Owing to these factors, these segmentsare expected to be a major revenue pockets for the HIE market in the coming years.

The high growth market segments in the HIE market include interfacing internal applications segment which is growing at a CAGR of 14.6% during the forecastperiod.The factors contributing to the growth include reliability and flexibility of healthcare data delivery.The platform centric segment is also projected to register a double-digit growth in the next five years, driven by the enhanced adoption rates due to rise in the clinical messaging and web portal applications. Investors are mainly focusing on the hybrid models segment as it provides the benefit of both federated and centralized models and helps in enhanced control of patient data and compatibility with several interfaces among communities.
Countries such as Japan, China, India, and South Korea will offer potential growth opportunities to HIE stakeholders. In Japan, various favorable government initiatives are focusing on strengthening healthcare services such as the e-Japan policy, New IT reform Strategy, and iJApan Strategy 2015. The healthcare IT expenditure in China grew from $135 billion in 2006 to $250 billion in 2010. In addition, Indian government annually spends approximately 5% of its GDP on the healthcare sector and has approved 100% FDI for setting up hospitals in India since 2000. All the above mentioned factors contribute to the potential growth opportunity if HIE market.

The grey area while estimating the market size is the cost of the HIE installations as most of theEHR vendors offer the HIE platformas a courtesy,which increased the difficulty level in estimating the market revenue gained through the installations.

The competitive landscape covers the growth strategies adopted by industry players in the last three years. The company profiles comprise the basic views on the key players in the HIE market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help the key players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Complete report spread across 198 pages available @ http://www.rnrmarketresearch.com/healthcare-information-exchange-hie-market-by-setup-types-public-private-vendors-web-portal-platform-implementation-models-centralized-federated-hybrid-application-interfacing-sec-market-report.html .

Few Points from Table Of Contents

Company Profiles

11.1 At&T, Inc.
11.2 Careevolution
11.3 Cerner Corporation
11.4 Ge Healthcare
11.5 IBM Corp.
11.6 Intersystems
11.7 Medicity
11.8 Oracle
11.9 Orion Health
11.10 Siemens Healthcare

Buy a copy of report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=155326 .

For further information on “Healthcare Information Exchange (HIE) Market by Setup Types (Public & Private), Vendors (Web Portal & Platform), Implementation Models (Centralized, Federated, & Hybrid), Application (Interfacing, Secure Messaging) – Global Trends & Forecast to 2018” report OR for any other business research / market intelligence need on the ‘Clinical Information System’ market (http://www.rnrmarketresearch.com/reports/life-sciences/healthcare/information-technology/clinical-information-system .) contact sales@rnrmarketresearch.com / Call +1 888 391 5441.

Global Clinical Decision Support System Market (CDSS) 2018

The report “Clinical Decision Support System (CDSS) Market [Product - Integrated (EHR, CPOE)], Model (Knowledge-based), Applications (Drug Allergy Alerts, Drug Interactions), Delivery Mode (Web-based, Cloud-based), (Hardware, Software)] – Global Forecast to 2018″ by MarketsandMarkets is now available at RnRMarketResearch.com. Contact sales@rnrmarketresearch.com with Clinical Decision Support System (CDSS) Market [Product - Integrated (EHR, CPOE)], Model (Knowledge-based), Applications (Drug Allergy Alerts, Drug Interactions), Delivery Mode (Web-based, Cloud-based), (Hardware, Software)] – Global Forecast to 2018 in subject line and your contact details to purchase this report or get your questions answered.

Countries across the globe are struggling to combat issues such as escalating healthcare costs, poor or inconsistent quality of healthcare, rapid expansion in healthcare insurance, and changing healthcare reform mandates. These are further exacerbated by growing consumerism, globalization, changing demographics and lifestyles, and growing incidences of diseases that are expensive to treat. Resolving these issues is a daunting task faced by healthcare stakeholders, highlighting the need for proactive, collaborative, and systemic models. Several initiatives and healthcare reforms have been developed in order to support the adoption and implementation of CDSS solutions.

Integrated EHR solution with CDSS and CPOE is estimated to be a high growth segment over the next five years. The high growth in this segment can be attributed to the growing demand for integrated CDSS with EHR and CPOE, as it meets all the needs of clinicians, from retrieving patient data to triggering alerts and reminders. Furthermore, this system helps to reduce the number of cases of medication errors.

Request a Sample @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=149890 .

For the healthcare industry, cloud computing has emerged as an efficient model to deliver various IT solutions. It enables the management and migration of huge amounts of data, helps in saving costs, offers anytime access from multiple mobile devices, provides large backup data storage capability, and offers ease-of-use. In terms of security, public cloud computing services are preferred in the healthcare industry, to meet HIPAA compliance. The growth in popularity and benefits offered by cloud computing have encouraged healthcare stakeholders to invest in this model for the delivery CDSS solutions. Owing to these factors, this segment is expected to be a major revenue pocket for the CDSS market in the coming years.

Countries such as China, India, Singapore, and Australia will also offer potential growth opportunities to CDSS stakeholders. Saudi Arabia and Brazil will also emerge as lucrative markets for CDSS vendors. In Saudi Arabia, various favourable government initiatives are focusing on strengthening healthcare services such as the e-Health program. The e-Health projects are aligned with the predefined goals of the Ministry of Health, which has made it mandatory to implement Information Communication Technology (ICT) in the country’s healthcare system. Similarly, the Brazilian government has launched a series of initiatives such as Prosoft, and Lei-de-Informatica and Renuncia Fiscal, to foster and promote clinical IT solutions. Improving financial support from government, coupled with various initiatives, is a significant factor providing impetus to the CDSS market growth.

Inquire a Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=149890 .

The global clinical decision support system market is dominated by MEDITECH (U.S.), followed by Zynx Health (U.S.), Cerner Corporation (U.S.), McKesson Corporation (U.S.), and EPIC (U.S.).
From an insight perspective, this research report focuses on the qualitative data, market size, share, and growth of various segments and sub-segments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis, such as market dynamics (drivers, restraints, opportunities, and threats), porter’s five forces analysis, and market share analysis based on cumulative installation, globally. The report also offers market shares, sizes, and related growth of various segments in the industry. It also focuses on the emerging and high-growth segments of CDSS (Integrated CDSS solutions and Knowledge-based CDSS solutions), high-growth regions, countries, and the initiatives of their respective governments.

The grey area while estimating the market size is the complex structure of CDSS solutions as it is composed of three parts. Of the three parts, a few parts are offered by third-party vendors, which increase the difficulty level while understanding the structure of CDSS solutions.

The competitive landscape covers the growth strategies adopted by industry players in the last three years. The company profiles comprise the basic views on the key players in the CDSS market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help the key players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Complete report spread across 242 pages available @ http://www.rnrmarketresearch.com/clinical-decision-support-system-cdss-market-product-integrated-ehr-cpoe-model-knowledge-based-applications-drug-allergy-alerts-drug-interactions-delivery-mode-web-based-cloud-base-market-report.html .

Few Points from Table Of Contents

Company Profiles

13.1 Cerner Corporation
13.2 Elsevier B.V.
13.3 EPIC
13.4 IBM Corporation
13.5 Mckesson Corporation
13.6 Medical Information Technology, Inc. (Meditech)
13.7 Philips Healthcare
13.8 Siemens Healthcare
13.9 Wolters Kluwer Health
13.10 Zynx Health

Buy a copy of report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=149890 .

For further information on “Clinical Decision Support System (CDSS) Market [Product - Integrated (EHR, CPOE)], Model (Knowledge-based), Applications (Drug Allergy Alerts, Drug Interactions), Delivery Mode (Web-based, Cloud-based), (Hardware, Software)] – Global Forecast to 2018” report OR for any other business research / market intelligence need on the ‘Clinical Information System’ market (http://www.rnrmarketresearch.com/reports/life-sciences/healthcare/information-technology/clinical-information-system .) contact sales@rnrmarketresearch.com / Call +1 888 391 5441.